Sponsor or institution
Clinical trials and research at Blokhin's Russian Cancer Research Center
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Blokhin's Russian Cancer Research Center that are recruiting, in Russia. By phase: Phase 2 (3), Phase 3 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
Paclitaxel-Bleomycin/Etoposide/Cisplatin vs BEP in poor-prognosis NSGCT with unfavorable tumor marker decline
This trial tests whether adding paclitaxel to BEP improves outcomes for patients with poor-prognosis non-seminomatous germ cell tumors who have unfavorable declines in tumor markers after initial BEP.
-
Sequential Gemcitabine Plus Docetaxel vs Gemcitabine Plus Mitomycin C for BCG-Unresponsive NMIBC
This study tests whether adding docetaxel after gemcitabine is better or worse than adding mitomycin C after gemcitabine for people with BCG-unresponsive high-grade non-muscle-invasive bladder cancer.
-
Olanzapine to prevent and treat appetite loss in cancer patients getting preoperative chemo
This study tests whether low-dose olanzapine can prevent and treat anorexia-cachexia and improve appetite and quality of life in adults with ovarian or gastric cancer undergoing neoadjuvant chemotherapy.
-
Molecular comparison of primary gastroesophageal cancers and their brain metastases
This project will test whether key biomarkers (HER2, MSI, PD-L1, CLDN18.2) match between primary gastroesophageal tumors and their matched brain metastases using archived tissue.
-
Trastuzumab deruxtecan for Russian patients with HER2-positive unresectable or metastatic breast cancer
This study will see how well trastuzumab deruxtecan (T-DXd) works in Russian adults with unresectable or metastatic HER2-positive breast cancer who received at least one cycle.
-
Combining Dabrafenib with FOLFOX and Cetuximab/Panitumumab for Metastatic Colorectal Cancer
This study is testing if a new combination of chemotherapy and targeted treatments can help people with metastatic colorectal cancer that has a specific mutation feel better and live longer.
-
Investigating genetic similarities between primary colorectal tumors and their brain metastases
This study is looking at the genetic similarities between original colorectal cancer tumors and their brain metastases to see how closely they match in terms of important gene mutations.
-
Using mesh to prevent hernias after stoma closure in rectal cancer patients
This study is testing if using a special mesh during stoma closure surgery can help prevent hernias in patients with rectal cancer.
-
Comparing neoadjuvant chemoradiotherapy and chemotherapy for esophageal cancer treatment
This study is testing whether a combination of chemotherapy and radiation before surgery is better than just chemotherapy before surgery for people with advanced esophageal cancer.
Quick answers
How many clinical trials run by Blokhin's Russian Cancer Research Center are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.